Three clinician researchers at the Peter MacCallum Cancer Centre have been promoted for their exceptional work in blood cancer and infectious diseases in cancer.

These are:

  • Professor Simon Harrison (formerly Associate Professor)
  • Associate Professor Gabrielle Haeusler (formerly Dr)
  • Associate Professor Benjamin Teh (formerly Dr)

Each have accepted new honorary clinical appointments within the Sir Peter MacCallum Department of Oncology at The University of Melbourne.

The appointments recognise outstanding leadership and practise-changing contributions to the fields of blood cancer for Professor Harrison, and infectious diseases in cancer for Associate Professors Haeusler and Teh.

Peter Mac Executive Director of Cancer Research, Professor Ricky Johnstone, congratulated the three appointees for taking the next step in their already outstanding careers.

“These clinician researchers are making a difference for patients both here in Melbourne and globally,” says Professor Johnstone.

“Through their many high-impact contributions to their fields they have driven changes in practise and improved outcomes from cancer care.

“We look forward to what’s yet to come.”

Professor Harrison is a highly respected clinical academic with an international profile for leadership in clinical research, teaching and professional practice, particularly in the treatment of the aggressive blood cancer multiple myeloma, and applications of the technology of apheresis (mechanical separation & collection of specific blood components). At Peter Mac, he has led clinical use of CAR T-cell therapy, a breakthrough immunotherapy in blood cancer.

Professor Harrison is Peter Mac’s Director of Centre of Excellence for Cellular Immunotherapy (since 2019), Head of the CAR-T Service (since 2019), Head of the Myeloma Service (since 2016) and Director of Clinical Apheresis (since 2009).

Associate Professor Haeusler has developed a new model of care which allows children with cancer to avoid a hospital stay, and instead be treated safely at home for the common childhood complication of febrile neutropenia.

This new model - which is being adopted internationally - saw Associate Professor Haeusler receive a Victorian Premier's Award for Excellence in Health and Medical Research in 2018.

Associate Professor Haeusler has a joint appointment at the Royal Children’s Hospital, and Murdoch Children’s Research Institute, and collaborative efforts across the Parkville precinct led by Associate Professor Haeusler have greatly enhanced the lives of many children.

Associate Professor Teh also received a Premier’s Award for Excellence in Health and Medical Research in 2018, recognising his work to improve the care of infections in blood cancer patients treated with new generation therapies.

Associate Professor Teh has led adoption at Peter Mac of new models of care - including the establishment, and running, of a multi-disciplinary post-stem cell transplant vaccination service which achieves near universal coverage of eligible Peter Mac patients. He continues to lead studies to reduce the impact of infections on patients with cancer.

Associate Professor Teh works collaboratively with Professor Marc Pelligrini at the Walter and Eliza Hall Institute, and the impact of his work is greatly enhanced through this mutually beneficial collaboration.


For more information contact the Peter Mac Communications team on 0417 123 048.

About Peter Mac

Peter MacCallum Cancer Centre is one of the world’s leading cancer research, education and treatment centres globally and is Australia’s only public hospital solely dedicated to caring for people affected by cancer. We have over 2,500 staff, including more than 650 laboratory and clinical researchers, all focused on providing better treatments, better care and potential cures for cancer.